Use of Hypotension Prediction Index to Reduce Intraoperative Hypotension in Major Thoracic Surgery
NCT ID: NCT05615168
Last Updated: 2022-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2022-01-01
2022-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The "Hypotension Prediction Index" in Patients Undergoing Lung Surgery
NCT04149314
The Hypotension Prediction Index in Major Abdominal Surgery
NCT06247384
HPI for Prevention of Hypotension During Cardiac Surgery
NCT06137547
Hypotension Prediction Index in Postoperative Surgical Patients
NCT05335174
Ability of Hypotension Prediction Index to Predict Hypotension Events in Thoracic Surgery
NCT05117151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AcumenIQ - HPI guided hemodynamic optimization
HPI guided hypotension prediction alarms... Interventions based on SVV (fluid), dp/dt (inotropes), EAdyn (pressors)
"Acumen IQ" guided hemodynamic optimization
Hypotension prediction index (HPI) available with the Edwards "Acumen IQ" sensor will be used as an early warning system and a "diagnostic screen" will be used to guide therapeutic interventions.
Flotrac - conventional GDT guided hemodynamic optimization
GDT guided hemodynamic optimization - MAP \> 65 mmHg, CI ≥ 2.4 l/min/m2, SVI ≥ 30 ml/beat/m2 and SVRI 1700-2400 dyn·s·cm-5/m2
"Flotrac" guided hemodynamic optimization
Therapeutic interventions guided by real time monitored hemodynamic parameters as measured by Edwards "Flotrac" sensor.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"Acumen IQ" guided hemodynamic optimization
Hypotension prediction index (HPI) available with the Edwards "Acumen IQ" sensor will be used as an early warning system and a "diagnostic screen" will be used to guide therapeutic interventions.
"Flotrac" guided hemodynamic optimization
Therapeutic interventions guided by real time monitored hemodynamic parameters as measured by Edwards "Flotrac" sensor.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients scheduled for elective major thoracic procedure (lung resection, pleurectomy or resection of the esophagus)
* planned thoracotomy and intraoperative period of one lung ventilation
* planned postoperative admission to the ICU
Exclusion Criteria
* structural heart defects (shunting or moderate to severe valvular anomalies)
* preoperative serum hemoglobin levels \< 120 g/L
* severe heart failure classified as New York Heart Association (NYHA) grade IV
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Dubrava
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrej Šribar
Prinicipal investigator, Head of division of cardiovascular anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Dubrava
Zagreb, City of Zagreb, Croatia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/1807-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.